DENTSPLY SIRONA (NASDAQ:XRAY) Updates FY 2026 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 1.400-1.500 for the period, compared to the consensus estimate of 1.490. The company issued revenue guidance of $3.5 billion-$3.6 billion, compared to the consensus revenue estimate of $3.7 billion.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY traded down $0.09 on Thursday, reaching $12.71. The stock had a trading volume of 6,878,332 shares, compared to its average volume of 4,692,243. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 1.36. The company has a market capitalization of $2.54 billion, a P/E ratio of -2.88, a price-to-earnings-growth ratio of 1.03 and a beta of 1.01. DENTSPLY SIRONA has a 1-year low of $9.85 and a 1-year high of $19.03. The stock has a fifty day moving average price of $12.32 and a 200-day moving average price of $12.47.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, February 26th. The medical instruments supplier reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). The business had revenue of $961.00 million during the quarter, compared to analyst estimates of $926.40 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were given a dividend of $0.16 per share. The ex-dividend date was Friday, December 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.0%. DENTSPLY SIRONA’s payout ratio is currently -14.48%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Barclays initiated coverage on DENTSPLY SIRONA in a report on Monday, December 8th. They issued an “underweight” rating and a $12.00 price target for the company. JPMorgan Chase & Co. lowered their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Zacks Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Tuesday, December 16th. Finally, Mizuho raised their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Tuesday, January 20th. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $14.46.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier sold 82,200 shares of the company’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.50% of the company’s stock.

Institutional Trading of DENTSPLY SIRONA

Institutional investors and hedge funds have recently bought and sold shares of the business. Virtu Financial LLC acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at about $302,000. Compound Planning Inc. acquired a new stake in DENTSPLY SIRONA in the 4th quarter worth about $117,000. Invesco Ltd. boosted its holdings in DENTSPLY SIRONA by 101.1% in the 4th quarter. Invesco Ltd. now owns 1,063,523 shares of the medical instruments supplier’s stock valued at $12,156,000 after purchasing an additional 534,714 shares during the period. Alpine Woods Capital Investors LLC acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $680,000. Finally, First Citizens Bank & Trust Co. acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $447,000. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.